Waters Corporation (NYSE:WAT) Director William J. Miller sold 3,500 shares of the company’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $194.94, for a total value of $682,290.00. Following the completion of the sale, the director now owns 25,849 shares in the company, valued at approximately $5,039,004.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Waters Corporation (NYSE WAT) traded down $0.41 during trading on Wednesday, reaching $194.26. The company’s stock had a trading volume of 307,900 shares, compared to its average volume of 515,291. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. Waters Corporation has a 1-year low of $133.71 and a 1-year high of $201.95. The stock has a market cap of $15,482.69, a price-to-earnings ratio of 27.04, a PEG ratio of 2.82 and a beta of 0.82.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.03. Waters had a return on equity of 23.61% and a net margin of 24.34%. The business had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same quarter in the prior year, the firm posted $1.57 EPS. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. sell-side analysts forecast that Waters Corporation will post 7.42 earnings per share for the current fiscal year.

A number of brokerages recently commented on WAT. Morgan Stanley upgraded Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 target price on the stock in a research report on Monday. Cowen reiterated a “hold” rating and issued a $190.00 target price on shares of Waters in a research report on Friday, November 3rd. Bank of America upped their target price on Waters from $192.00 to $202.00 and gave the company a “neutral” rating in a research report on Friday, November 10th. Zacks Investment Research lowered Waters from a “buy” rating to a “hold” rating in a research report on Thursday, October 26th. Finally, Citigroup reiterated a “neutral” rating and issued a $180.00 target price on shares of Waters in a research report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $193.62.

A number of institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in Waters by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 7,704,022 shares of the medical instruments supplier’s stock worth $1,416,308,000 after purchasing an additional 206,262 shares in the last quarter. BlackRock Inc. raised its stake in shares of Waters by 3.1% during the 2nd quarter. BlackRock Inc. now owns 5,515,322 shares of the medical instruments supplier’s stock worth $1,013,936,000 after buying an additional 165,611 shares during the period. Fundsmith LLP raised its stake in shares of Waters by 11.7% during the 2nd quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after buying an additional 401,420 shares during the period. Harding Loevner LP raised its stake in shares of Waters by 207.1% during the 3rd quarter. Harding Loevner LP now owns 2,768,174 shares of the medical instruments supplier’s stock worth $158,275,000 after buying an additional 1,866,848 shares during the period. Finally, Janus Henderson Group PLC raised its stake in shares of Waters by 1.6% during the 3rd quarter. Janus Henderson Group PLC now owns 1,959,850 shares of the medical instruments supplier’s stock worth $351,832,000 after buying an additional 30,057 shares during the period. Institutional investors and hedge funds own 92.29% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Waters Corporation (WAT) Director Sells $682,290.00 in Stock” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.americanbankingnews.com/2017/12/06/waters-corporation-wat-director-sells-682290-00-in-stock.html.

Waters Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.